For nearly 30 years, Mr. John Taylor has made significant contributions to public health serving in senior leadership positions at the Food and Drug Administration (FDA), industry, and consulting services. This trio of experiences positions him with a firm understanding of the relationship between the stakeholders impacted by USP standards and the regulatory framework where these standards operate.
Mr. Taylor is currently the President and Principal of Compliance and Regulatory Affairs at Greenleaf Health where he provides strategic consultation to FDA-regulated clients on enforcement and compliance matters. As an industry veteran, he served as Executive Vice President for Health at the Biotechnology Industry Organization (BIO) and as Divisional Vice President for Federal Government Affairs at Abbott.
Mr. Taylor spent over 20 years at the FDA, culminating in several leadership roles. As Acting Deputy Commissioner for Global Regulatory Operations and Policy, he led and directed more than 4,000 employees in the FDA’s Office of Regulatory Affairs and Office of International Programs. He also served in two other high-profile positions at FDA, including Counselor to the Commissioner and Acting Deputy Principal Commissioner. When Mr. Taylor joined the FDA, he began as an attorney within FDA’s Office of the Chief Counsel where he was responsible for all phases of criminal and civil litigation related to violations of the Federal Food, Drug, and Cosmetic Act and other federal laws.
Mr. Taylor received his J.D. from the College of William and Mary and a B.A. in History from the Pennsylvania State University.